eClinical Solutions Market worth $25.22 billion by 2030 | MarketsandMarkets™

DELRAY BEACH, Fla., Jan. 28, 2026 /PRNewswire/ — According to MarketsandMarkets, the eClinical Solutions Market is projected to grow from about USD 13.18 billion in 2025 to USD 25.22 billion by 2030, at a CAGR of 13.9%.

Browse 252 market data Tables and 52 Figures spread through 306 Pages and in-depth TOC on ‘eClinical Solutions Market – Global Forecast to 2030’

eClinical Solutions Market Size & Forecast:

• Market Size Available for Years: 2024–2030
• 2025 Market Size: USD 13.18 billion
• 2030 Projected Market Size: USD 25.22 billion
• CAGR (2025–2030): 13.9%

eClinical Solutions Market Trends & Insights:

• The electronic data capture & clinical data management solutions segment dominated the eClinical solutions market, with a share of 20.8% in 2024.
• The web-based & cloud-based models segment is projected to register a higher CAGR (14.0%) than the on-premises model segment during the forecast period.
• North America dominated the eClinical solutions market, with a share of 47.7% in 2024.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=553 

The eClinical solutions market is driven by the rising use of technology, which helps remove repetitive tasks that individual team members have to do during the course of a clinical trial. Other drivers entail the increasing need to reduce time and cost burdens on clinical trials. Additionally, stringent regulatory requirements make it essential for data management to follow all compliance measures that can easily be done by eClinical solutions. Moreover, the increasing adoption of cloud-based technologies offers scalability, flexibility, and cost-efficiency in managing large volumes of clinical trial data securely. However, factors such as integrating eClinical solutions with existing healthcare IT infrastructure can be challenging, as they require technical expertise and may potentially cause compatibility issues. High upfront cost associated with implementing and maintaining these complex systems is further expected to restrain market growth to some extent.

By product, the electronic clinical outcome assessment solutions segment is projected to grow at the highest rate during the forecast period.

The electronic clinical outcome assessment solutions segment is projected to be the fastest-growing segment in the eClinical solutions market. Fueled by the swift change to decentralized trials, digital endpoints continue to gain acceptance at the regulatory level, and mobile technology is increasingly prevalent. Additionally, eCOA decreases the workload for study sites and minimizes the risk of transcription mistakes. At the same time, it increases patient compliance, making eCOA a key enabler for global clinical trials.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=553

By clinical trial phase, the phase IV segment is projected to grow at the highest rate during the forecast period.

the phase IV segment is projected to grow at the highest rate during the forecast period. The increasing focus on post-marketing surveillance, real-world evidence generation, and long-term safety monitoring drives the growth of the segment. Growth is further supported by wider use of digital data collection tools, eCOA, and analytics to track treatment outcomes in broader patient populations. These factors are helping sponsors meet regulatory requirements and optimize lifecycle management strategies.

Asia Pacific is projected to be the fastest-growing market during the forecast period.

Asia Pacific is projected to be the fastest-growing market for eClinical solutions during the forecast period. This projection is driven by a rapid increase in clinical trial activity, expanding pharmaceutical R&D investments, and growing adoption of cloud-based and decentralized trial technologies. The region benefits from large patient pools, cost-efficient trial execution, improved regulatory frameworks, and increasing participation of global sponsors and CROs, which is also accelerating the demand for advanced eClinical platforms across emerging economies.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=553

Top Companies in eClinical Solutions Market:

The Top Companies in eClinical Solutions Market include Medidata (Dassault Systèmes Company) (France), Veeva Systems (US), IQVIA (US), ICON Plc (Ireland), Oracle (US), Signant Health (US), Clario (US), eClinical Solutions LLC (US), Clinion (US), MaxisIT (US), 4G Clinical (US), Fountayn (US), Saama (US), Suvoda LLC (US), Advarra (US), Caidya (US), OpenClinica, LLC (US), EvidentIQ (US), Ennov (France), and Perceptive (US).

Browse Adjacent Markets: Healthcare IT Market Research Reports & Consulting

Related Reports:

Healthcare Analytics Market – Global Forecast to 2030

Drug Discovery Services Market – Global Forecast to 2030

Clinical Trial Supplies Market – Global Forecast to 2030

Healthcare IT Market – Global Forecast to 2030

Clinical Trial Services Market – Global Forecast to 2030

About MarketsandMarkets 

MarketsandMarkets has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/eclinical-solutions-market-worth-25-22-billion-by-2030–marketsandmarkets-302672369.html

SOURCE MarketsandMarkets